Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis

被引:6
|
作者
McLinden, Taylor [1 ]
Moodie, Erica E. M. [1 ]
Hamelin, Anne-Marie [1 ]
Harper, Sam [1 ]
Rossi, Carmine [1 ]
Walmsley, Sharon L. [2 ,3 ]
Rourke, Sean B. [4 ,5 ,6 ]
Cooper, Curtis [7 ]
Klein, Marina B. [8 ,9 ]
Cox, Joseph [1 ,8 ,9 ]
机构
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ H3A 1A2, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada
[4] Ontario HIV Treatment Network, Toronto, ON, Canada
[5] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[6] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[7] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[8] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada
[9] CIHR Canadian HIV Trials Network, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
Methadone treatment; Severe food insecurity; HIV; Hepatitis C virus; Propensity score matching; INFECTED INDIVIDUALS; C VIRUS; PREVALENCE; PEOPLE;
D O I
10.1016/j.drugalcdep.2017.12.031
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Severe food insecurity (FI) is common among individuals living with HIV-hepatitis C virus (HCV) co-infection. We hypothesize that the injection of opioids is partly responsible for the association between injection drug use and severe FI. Therefore, this analysis examines whether methadone maintenance treatment for opioid dependence is associated with a lower risk of severe Fl. Methods: We used biannual data from the Canadian Co-infection Cohort (N = 608, 2012-2015). Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module. To quantify the association between methadone treatment and severe FI, we estimated an average treatment effect on the treated (marginal risk difference [RD]) using propensity score matching. Results: Among participants, 25% experienced severe FI in the six months preceding the first time-point in the analytical sample and 5% concurrently reported receiving methadone treatment. Injection of opioids in the six months preceding the treatment and outcome measurements was much higher among those who received methadone treatment (39% vs. 12%). Among the treated participants, 97% had injected opioids in their lifetimes. After propensity score matching, the average risk of experiencing severe FI is 12.3 percentage-points lower among those receiving methadone treatment, compared to those who are not receiving treatment (marginal RD = -0.123, 95% CI = -0.230, 0.015). Conclusions: After adjustment for socioeconomic, sociodemographic, behavioural, and clinical confounders, methadone treatment is associated with a lower risk of severe FI. This finding suggests that methadone treatment may mitigate severe FI in this vulnerable subset of the HIV-positive population.
引用
收藏
页码:374 / 380
页数:7
相关论文
共 50 条
  • [1] Injection drug use, food insecurity, and HIV-HCV co-infection: a longitudinal cohort analysis
    McLinden, Taylor
    Moodie, Erica E. M.
    Harper, Sam
    Hamelin, Anne-Marie
    Anema, Aranka
    Aibibula, Wusiman
    Klein, Marina B.
    Cox, Joseph
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (10): : 1322 - 1328
  • [2] HIV-HCV co-infection
    Daruich, J.
    HAEMOPHILIA, 2008, 14 : 38 - 38
  • [3] Managing HIV-HCV co-infection
    Rockstroh, J.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 7 - 7
  • [4] HIV-HCV co-infection: conflicts in treatment and clinical outcome
    Rommel, F
    HAEMOPHILIA, 2000, 6 : 37 - 38
  • [5] HIV-HCV co-infection among blood donors
    Mukonde, Frank
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [6] HIV-HCV Co-infection Among Blood Donors
    Frank Mukonde
    Retrovirology, 2
  • [7] HIV-HCV co-infection: where are we now?
    Piroth, L.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 : S94 - S96
  • [8] HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications
    Andreoni, M.
    Giacometti, A.
    Maida, I.
    Meraviglia, P.
    Ripamonti, D.
    Sarmati, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (11) : 1473 - 1483
  • [9] Evaluation of the HIV-HCV co-infection status in a cohort of southeastern of Spain
    Moreno Hernandez, A.
    Smilg Nicolas, C.
    Vera Mendez, F.
    Martinez Madrid, O.
    Jimeno Almazan, A.
    Alcalde Encinas, M.
    Alcaraz Vidal, B.
    Trujillo Santos, J.
    Tornel Sanchez, G.
    Vega Cervantes, J.
    Mozo Cuadrado, M.
    Belmonte Martinez, L.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 89 - 90
  • [10] Liver enzymes elevation after HAART in HIV-HCV co-infection
    Servin-Abad, L
    Molina, E
    Baracco, G
    Arosemena, L
    Regev, A
    Jeffers, L
    Schiff, E
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (04) : 429 - 434